Updated with revised EMA Guidance and new FDA Insight Podcasts
Safety of our DIA community remains our priority as we monitor the COVID-19 outbreak and follow updates from the WHO and others

Learn More
INSIDER ACCESS: DIA Member Exclusive - New Pharmacovigilance Regulations: Key Insights?: Watch the video, follow the interactive transcript, or download the audio.
Start Exploring
Improving Access to CAR T Therapy: It’s Not Just Payment

Time for payment science to catch up: If CAR T foretells an expensive innovative future, we must work to ensure affordable access
Read Now
PODCAST: Regulators Promote Reliance as 21st Century Best Practice

When time is of the essence in a pandemic, regulators are still called to be scientifically robust but not to be redundant
Listen Now
Coronavirus Disease 2019 (COVID-19) Spread and Pharmacovigilance Implications

Regulatory scientists must be vigilant to ensure rational medicine use despite global panic
Read More
How Does DIA Membership Benefit You?
Connect with global influencers, and uncover ways to deliver impactful change
Access new knowledge that keeps you on the cutting-edge of healthcare conversations
Advance career development goals through best-in-class learning programs
Open doors to new pathways towards leadership growth
Expand your network to include global peers who support one another in real time
Christi Marsh
"DIA quickly became a valuable place not only for education, but for networking and leadership growth as well. Today, it just feels like a large professional family that I really could not do without."
Christi Marsh
Director, Medical Affairs, Medical Information & Scientific Communication, HEMA Biologics, LLC
Atsushi Tsukamoto
“DIA is a very unique opportunity for me to both express my opinions and listen to the opinions of my colleagues across regulatory, industry and academia. We all get together to discuss important topics very openly and freely. Plus, it’s fun!"
Dr. Atsushi Tsukamoto
Vice President, New Drug Regulatory Affairs Department, Development Function, R&D Division, Daiichi Sankyo Co. Ltd.
Christi Marsh
"DIA quickly became a valuable place not only for education, but for networking and leadership growth as well. Today, it just feels like a large professional family that I really could not do without."
Christi Marsh
Director, Medical Affairs, Medical Information & Scientific Communication, HEMA Biologics, LLC
Atsushi Tsukamoto
“DIA is a very unique opportunity for me to both express my opinions and listen to the opinions of my colleagues across regulatory, industry and academia. We all get together to discuss important topics very openly and freely. Plus, it’s fun!"
Dr. Atsushi Tsukamoto
Vice President, New Drug Regulatory Affairs Department, Development Function, R&D Division, Daiichi Sankyo Co. Ltd.
Global Forum, DIA's Digital Magazine
Uncover expert insights through global and regional coverage of the discovery, development, regulation, surveillance, and marketing of healthcare products, including interviews with thought leaders and topical summaries from educational events.
DIA's Podcast Channel
Get inside the minds of life science leaders as they share perspectives on current issues in healthcare product development, and the potential paths that lie ahead.